News | Radiology Business | April 24, 2019

Team coverage of gadolinium controversy earns ITN first “Pulitzer Prize of the business press”

ITN Wins Jesse H. Neal Award for Best Technical Content

April 24, 2019 — Imaging Technology News (ITN) was recently named the 2019 Jesse H. Neal Award winner in the Best Technical Content category for its team coverage of the topic of gadolinium.

The Jesse H. Neal Awards, sponsored and hosted by Connectiv, a division of the Software & Information Industry Association, are recognized as the “Pulitzer Prize of the business press.” The winners are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship. 2019 marked the first Neal Awards win in ITN’s history.

Gadolinium has become a hot-button patient safety issue in radiology due to a possible link to neurological disorders in some patients who undergo a magnetic resonance imaging (MRI) scan using a gadolinium contrast agent. A 2015 study showed small levels of gadolinium, a heavy metal, remained deposited in the brain following repeated intravenous exposures to gadolinium-based contrast agents (GBCAs). The issue was also fueled by numerous patient groups claiming they suffer from numerous unexplained health issues after gadolinium exams, and movie star Chuck Norris filed a high-profile lawsuit alleging gadolinium permanently harmed his wife.

ITN editors joined several gadolinium patient groups on Facebook and read through hundreds of posts to gather the patient perspective. These groups were asked what questions they wanted posed to key MRI thought leaders, resulting in hundreds of comments. The responses formed the basis for interviews at the 2017 Radiological Society of North America (RSNA) meeting. ITN also shot video interviews with thought leaders and attended several sessions on this topic. The article was published online in February 2018. While written for radiologists, it was also geared it to be a resource for patients. It outlines the chemistry of gadolinium agents, symptoms patients report and regulatory actions taken. Extra search engine optimization (SEO) helped it on Google to appear on Page 1 of all searches for the topic. The result was was the best performing article ever on ITN, with more than 93,000 pageviewsin 2018. This one article now outperforms ITN's homepage traffic.

Click here to see all the 2019 Jesse H. Neal Awards winners.

For more information: www.itnonline.com

Related Content of MRI Gadolinium Safety Concerns

VIDEO: How Serious is MRI Gadolinium Retention in the Brain and Body? An interview with Max Wintermark, M.D.

VIDEO “Big Concerns Remain for MRI Gadolinium Contrast Safety at RSNA 2017,” An interview with Emanuel Kanal, M.D.

Radiology Has Failed to Properly Assess or Track MRI Gadolinium Contrast Safety

Recent Developments in Contrast Media

FDA Committee Votes to Expand Warning Labels on Gadolinium-Based Contrast Agents

European Medicines Agency Issues Update on Gadolinium Contrast Agents

ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents

FDA: No Harm in MRI Gadolinium Retention in the Brain

VIDEO: MRI Gadolinium Contrast Retention in the Brain

Gadolinium May Remain in Brain After Contrast MRI


Related Content

News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Enterprise Imaging

May 16, 2024 — AGFA HealthCare announced that St. Vincent’s Private Hospital in Dublin, Ireland, has chosen to implement ...

Time May 16, 2024
arrow
News | Artificial Intelligence

May 16, 2024 — deepc, the globally recognized digital medicine pioneer and market leader behind the leading AI operating ...

Time May 16, 2024
arrow
News | Enterprise Imaging

May 15, 2024 — etherFAX announced the expansion of its partnership with Hyland, a leading global provider of intelligent ...

Time May 15, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Prostate Cancer

May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...

Time May 13, 2024
arrow
News | Cybersecurity

May 13, 2024 — In the wake of the cybersecurity breach targeting the prominent healthcare system Ascension, a new study ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | ARRS

May 8, 2024 — Compared to males, women in radiology are at a consistently higher risk of not matching into diagnostic ...

Time May 08, 2024
arrow
Subscribe Now